Home > Insider Trading > Filing (0001140361-12-039191)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070698	Raptor Pharmaceutical Corp	RPTP	Pharmaceutical Preparations (2834)	860883978

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1362490	Todd Zankel	C/O Raptor Pharmaceutical Corp. 9 Commercial Blvd., Suite 200 Novato CA 94949	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2012-08-30	2,648	$5.00	656,566	No	4	S	Direct
Common Stock	Acquisiton	2012-08-31	3,642	$2.83	660,208	No	4	M	Direct
Common Stock	Disposition	2012-08-31	3,642	$5.00	656,566	No	4	S	Direct
Common Stock	Disposition	2012-08-31	3,858	$5.00	652,708	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock options (right to buy)	Disposition	2012-08-31	3,642	$0.00	3,642	$2.83

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
308,921	2006-11-25	2016-05-25	No	4	M	Direct

Footnotes

Transaction made pursuant to a Rule 10b5-1 trading plan executed on January 9, 2012.
Original option grant vests 6/36ths on November 25, 2006 and 1/36th per month thereafter.
This transaction was executed in multiple trades at prices ranging from $5.00 to $5.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.